Business
AstraZeneca/Oxford COVID-19 vaccine approved in Britain – Sydney Morning Herald
Britain on Wednesday became the first country in the world to approve the vaccine developed by Oxford University as it battles a highly contagious virus strain.
AstraZeneca and other developers have said they are studying the impact of the new variant but expect that their shots will be effective against it.
Regulatory endorsement is a welcome boost for AstraZeneca and the Oxford team, which have been accused of a lack of clarity about the results from late-stage trials.
Pooled results from those trials show it had overall efficacy was 70.4 per cent. Efficacy was 62 per cent for trial participants given two full doses, but 90 per cent for a smaller sub-group…
Continue Reading
